Urinary tract infections in girls: The cost-effectiveness of currently recommended investigative routines

被引:50
|
作者
Stark, H
机构
[1] Department of Pediatric Nephrology, Western Galilee Regional Hospital, Nahariya
关键词
urinary tract infection; girls; prognosis; investigation; imaging; cost-effectiveness;
D O I
10.1007/s004670050252
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Current recommendations for the universal investigation of urinary tract infection (UTI) in children by ultrasonography, voiding cystourethrography, mercaptosuccinic acid renal scan (and sometimes intravenous pyelography as well) are not based on any convincing evidence as to the necessity or effectiveness of such a routine. Over 8% of all girls will have a UTI during childhood. About 87 individuals in a million will develop end-stage renal disease (ESRD) by the age of 60 years, caused in about 9% by pyelonephritis (PN) or reflux nephropathy. From these statistics, the maximal risk of a first diagnosed UTI progressing to ESRD is approximately 1:10,000. The risk of developing hypertension following a first UTI in childhood, without eventual evolution to ESRD, appears to be very small. The cost of the widely recommended routine imaging procedures ranges from U.S. $ 355 in Britain to U.S. $ 1,090 in the United States. The minimal cost of preventing a single progression to ESRD by early diagnosis of underlying pathology - if this were possible in all cases - would range between U.S. $ 5 million in Britain and U.S. $ 15 million in the United States. Since in many instances progressive renal damage can not be prevented, the true cost is considerably higher. Lower UTI in girls is a very common and, in most cases, benign finding in primary-care practice. It is suggested that girls with afebrile UTI, presenting with lower urinary tract symptoms alone, need not undergo any imaging procedures, but should be followed with urine examinations and cultures at the time of febrile illness. The recommended investigative routines should be reserved for UTI in infants and in girls with fever or other symptoms suggesting PN, and for proven recurrent Un. Such a regimen will allow a marked saving in terms of costs and in terms of unneccessary radiation, psychological stress to children, and stress, inconvenience, and time loss to parents. There is no evidence that this approach will compromise the course or final outcome of this very common condition.
引用
收藏
页码:174 / 177
页数:4
相关论文
共 50 条
  • [21] Rapid antibiotic susceptibility testing for urinary tract infections in secondary care in England: a cost-effectiveness analysis
    Booton, Ross D.
    Agnew, Emily
    Pople, Diane
    Evans, Stephanie
    Bock, Lucy J.
    Sutton, J. Mark
    Robotham, Julie, V
    Naylor, Nichola R.
    BMJ OPEN, 2024, 14 (11):
  • [23] Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care
    Bosmans, Judith E.
    Coupe, Veerle M. H.
    Knottnerus, Bart J.
    Geerlings, Suzanne E.
    van Charante, Eric P. Moll
    ter Riet, Gerben
    PLOS ONE, 2017, 12 (11):
  • [24] Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections
    Kongnakorn, Thitima
    Wagenlehner, Florian
    Falcone, Marco
    Tichy, Eszter
    Di Virgilio, Roberto
    Baillon-Plot, Nathalie
    Charbonneau, Claudie
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (05) : 633 - 641
  • [25] The cost-effectiveness of placing urinary tract infection treatment over the counter
    Rubin, N
    Foxman, B
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (11) : 1315 - 1321
  • [26] Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
    Bosmans, Judith E.
    Beerepoot, Marielle A. J.
    Prins, Jan M.
    ter Riet, Gerben
    Geerlings, Suzanne E.
    PLOS ONE, 2014, 9 (04):
  • [27] COST-EFFECTIVENESS EVALUATION OF ERTAPENEM IN THE TREATMENT OF ADULT PATIENTS WITH COMMUNITY-ACQUIRED COMPLICATED URINARY TRACT INFECTIONS
    Romero, M.
    Barrera, J.
    Carrasquilla-Sotomayor, M.
    Ruiz, J.
    Lopez, M. C.
    Rojas, M.
    Beltran, C.
    VALUE IN HEALTH, 2018, 21 : S153 - S153
  • [28] Management of urinary tract infection in general practice: a cost-effectiveness analysis
    Fenwick, EAL
    Briggs, AH
    Hawke, CI
    BRITISH JOURNAL OF GENERAL PRACTICE, 2000, 50 (457): : 635 - 639
  • [29] The application of cost effectiveness analysis to derive a formulary for urinary tract infections
    Tramarin, A
    Bragagnolo, L
    Tolley, K
    Sartorelli, S
    Tositti, G
    Lazzarini, L
    Scagnelli, M
    Gallo, R
    Postma, MJ
    De Lalla, F
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (02) : 166 - 174
  • [30] PROGNOSIS IN CHILDHOOD URINARY TRACT INFECTIONS IN GIRLS
    WOODRUFF, JD
    EVERETT, HS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1954, 68 (03) : 798 - 809